Connection

Jochen Schneider to Cross-Sectional Studies

Back to Details
This is a "connection" page, showing publications Jochen Schneider has written about Cross-Sectional Studies.
Jochen Schneider
Connection Strength
0.008
Cross-Sectional Studies
  1. Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany. Infection. 2021 Dec; 49(6):1313-1318.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.